APA (7th ed.) Citation

TH, C., J, M., S, S., I, T., I, S., MD, W., . . . SS, S. (2026). Evaluating the Impact of Blood-Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive Disorders. Journal of acquired immune deficiency syndromes (1999), 101(6), 663. https://doi.org/10.1097/QAI.0000000000003847

Chicago Style (17th ed.) Citation

TH, Cummings, Magagnoli J, Sikirzhytskaya S, Tyagin I, Safro I, Wyatt MD, Shtutman M, and Sutton SS. "Evaluating the Impact of Blood-Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive Disorders." Journal of Acquired Immune Deficiency Syndromes (1999) 101, no. 6 (2026): 663. https://doi.org/10.1097/QAI.0000000000003847.

MLA (9th ed.) Citation

TH, Cummings, et al. "Evaluating the Impact of Blood-Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive Disorders." Journal of Acquired Immune Deficiency Syndromes (1999), vol. 101, no. 6, 2026, p. 663, https://doi.org/10.1097/QAI.0000000000003847.